What sector does Aligned Genetics, Inc. belong to?

Aligned Genetics, Inc. operates in the Technology sector, specifically the Technology industry, and is listed on the US markets.

What is the current share price of 238120?

As of the latest available quote, 238120 traded at ₩2,940.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 238120?

Aligned Genetics, Inc. has a price-to-earnings (P/E) ratio of about 14.27. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 238120?

The market capitalisation of Aligned Genetics, Inc. is approximately ₩41.55B.

Is Aligned Genetics, Inc. profitable?

For its latest reported financial year, Aligned Genetics, Inc. recorded a net profit margin of about 18.18%.

What is the return on equity (ROE) of 238120?

Aligned Genetics, Inc. has a return on equity (ROE) of about 7.83%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 238120?

Over the past 52 weeks, 238120 has traded between a low of ₩2,380.00 and a high of ₩6,050.00.

Aligned Genetics, Inc.

238120 KRX Technology Technology

KOSDAQ

₩2,940.00

-1.51%

Delayed · cached 15 min

Fair value analysis

238120

Aligned Genetics, Inc.

₩2,940.00

Close used for this calculation

₩3,717.65Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

61/100

Profitability23/25

Returns6/25

Balance Sheet15/25

Efficiency17/25

Growth20/25

Good

Quality radar

Consensus fair value

₩3,717.65

Below FV

▲ +26.5% against the close used

Model range ₩1,211.76 – ₩13,321.33

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩1,211.76Fair value₩3,717.65Bull₩13,321.33

FairClose

52-week traded range

52W low ₩2,680.0052W high ₩6,050.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Aligned Genetics, Inc. closed at ₩2,940.00, 20.9% below the consensus fair value of ₩3,717.65 drawn from 9 valuation models.

Financial DNA score 61/100 — Good. P/E of 14.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩4,088.90

+39.1%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₩3,503.78

+19.2%

√(22.5 × EPS × BVPS)

EPS=206, BVPS=2648.65

Graham Formula

₩13,321.33

+353.1%

EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate

g=20%, FD=3.3%

P/E Fair Value

₩4,120.00

+40.1%

EPS × 20x (sector P/E)

EPS=206, Sector P/E=20x

Peter Lynch (PEG)

₩6,180.00

+110.2%

EPS × Growth% (PEG = 1 is fair)

EPS=206, g=30%

EV/EBITDA

₩2,272.83

-22.7%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=2.44B

Book Value (P/B)

₩1,211.76

-58.8%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=2648.65, ROE=7.8%, g=6%, r=10%

Reverse DCF

₩2,940.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 2.6% | Historical: 70.9%

Margin of Safety

₩4,693.88

+59.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=6258.5, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer